RAJANI PATEL: Open Payments
NPI 1386618742 · BRISTOL, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$361 in 31 payments from 8 companies in 2025. Trend: 2023 $290 · 2024 $171 · 2025 $361
Food & beverage: $361
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 21 | $141 |
| E.R. Squibb & Sons, L.L.C. | 3 | $82 |
| Otsuka America Pharmaceutical, Inc. | 2 | $52 |
| Teva Pharmaceuticals USA, Inc. | 1 | $18 |
| Indivior Inc. | 1 | $18 |
| Lundbeck LLC | 1 | $17 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $17 |
| Janssen Pharmaceuticals, Inc | 1 | $16 |
Products named: VRAYLAR, COBENFY, ABILIFY ASIMTUFII, UZEDY, SUBLOCADE, REXULTI, CAPLYTA, SPRAVATO.
Industry payments across PA — which companies pay providers there.
